Navigation Links
Clontech Laboratories, Inc. Releases the SMARTer™ Ultra Low RNA Kit for Illumina® Sequencing
Date:3/31/2011

expression in individual cells that was not previously possible.  The ability to assay the expression of individual neurons from brain slices, which we have done, allows one to correlate changes in the electrophysiology of each cell to changes in gene expression."

The SMARTer Ultra Low RNA Kit for Illumina Sequencing has been designed and validated to prepare cDNA samples for sequencing on all of Illumina's sequencing instruments, including HiSeq™ 2000. This kit greatly reduces handling of the RNA sample, thereby minimizing the risk of sample loss and preserving the original message. The efficient incorporation of known sequences at both ends of the cDNA during first strand synthesis enables researchers to perform the entire protocol in a single tube, without a separate adaptor ligation step. Moreover, SMART's high efficiency and sensitivity permits the use of very limited quantities of starting material—as little as 100 pg of total RNA—from a variety of sources. The combination of SMART technology's ability to handle very small quantities of RNA with Illumina's unique combination of long and short reads, single and paired-end sequencing, and capacity for tens of millions to billions of reads per run allows you to annotate coding SNPs, discover transcript isoforms, characterize splice junctions, and determine the relative abundance of transcripts from even the smallest samples.

About Clontech Laboratories, Inc.

Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., develops, manufactures, and distributes a wide range of life science research reagents under the Clontech and Takara brands. Key products include high-performance qPCR and PCR reagents (including the Ex Taq™, LA Taq™, Titanium®, and Advantage® enzymes); RT enzymes and SMART and SMARTer library construction kits; the innovative In-Fusion® cloning system; Tet-based inducible gene expression syste
'/>"/>

SOURCE Clontech Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Clontech Laboratories, Inc. Recognizes the 2008 Winners of the Nobel Prize in Chemistry
2. Clontech Laboratories, Inc. Releases the Xfect(TM) and Xfect(TM) Stem Transfection Reagents
3. Getting Ready Corporation and Winston Laboratories, Inc. Announce Completion of Merger
4. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2009 Second Quarter Earnings
5. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal 2009
6. Caraco Pharmaceutical Laboratories, Ltd. Receives FDA Warning Letter
7. Roxane Laboratories, Inc. Announces the Launch of Mycophenolate Mofetil 250mg Capsules and 500mg Tablets
8. Charleston Laboratories, Inc. Completes Exploratory Bioequivalence Study of CL-108
9. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Casodex(R) Tablets
10. DermTech and Stiefel Laboratories, Inc. to Further Evaluate EGIR(TM) Technology
11. MO BIO Laboratories, Inc. Launches PowerWater(R) RNA Isolation Kit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 19, 2014 The new , Healthcare ... , available today on PharmaBoardroom.com for free ... that rocked the Spanish economy in 2009, and the austerity ... has remained pragmatic in times of trouble. "Despite ... fifth biggest European market, and the general conditions to invest ...
(Date:9/18/2014)... -- About POCT POCT, also ... laboratory. It helps in making fast clinical decisions, ... POCT is gaining popularity due to the increasing ... diabetes, heart disease, and obesity. It is generally ... minimize errors during the diagnosis of patients. POCT ...
(Date:9/18/2014)... HARBOR, Mich. , Sept. 18, 2014  Health Enhancement ... biotech firm investigating early-stage algae bioactive compounds and metabolic processes, ... to the company,s board of directors. Ms. Nola E. ... and investment advisor joined the board effective September 17, 2014. ... Ms. Masterson agree to join our board," states Andrew ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 On Tuesday, ... and Sen. Jim Risch for National Lab Day on ... from across the national laboratory system. Durbin and Risch ... aims to increase awareness of the reach of the ... and discoveries to address some of our nation's most ...
Breaking Biology Technology:PharmaBoardroom Releases New Spain Pharmaceuticals Report 2PharmaBoardroom Releases New Spain Pharmaceuticals Report 3POCT Market in China 2014-2018 2Health Enhancement Announces New Board Member In Advance Of Annual Shareholder Meeting 2Lab Day Highlight Labs' Contribution to U.S. Competitiveness and Innovation 2Lab Day Highlight Labs' Contribution to U.S. Competitiveness and Innovation 3
... (Nasdaq: PBIO ) ("PBI" or the "Company") today ... was $334,041 compared to $174,071 for the comparable period in ... PCT products and services was $233,256 for the three months ... period in 2007, a 97% increase. During the fourth ...
... 4 Tigris Pharmaceuticals, Inc., a privately held ... New Drug (IND) application for the Company,s geranylgeranyltransferase ... Food and Drug Administration. This will allow the ... the safety of GGTI-2418 during the first quarter ...
... Head of Nektar Therapeutic,s Pulmonary Business Unit, Among ... Savara, Inc., a biopharmaceutical company developing novel ... today announced that it has expanded its Board ... Elam, former head of the pulmonary business unit ...
Cached Biology Technology:Pressure BioSciences, Inc. Reports Record Revenue, Significantly Reduced Operating Loss for the Fourth Quarter of 2008 2Pressure BioSciences, Inc. Reports Record Revenue, Significantly Reduced Operating Loss for the Fourth Quarter of 2008 3Pressure BioSciences, Inc. Reports Record Revenue, Significantly Reduced Operating Loss for the Fourth Quarter of 2008 4Pressure BioSciences, Inc. Reports Record Revenue, Significantly Reduced Operating Loss for the Fourth Quarter of 2008 5Pressure BioSciences, Inc. Reports Record Revenue, Significantly Reduced Operating Loss for the Fourth Quarter of 2008 6Pressure BioSciences, Inc. Reports Record Revenue, Significantly Reduced Operating Loss for the Fourth Quarter of 2008 7Pressure BioSciences, Inc. Reports Record Revenue, Significantly Reduced Operating Loss for the Fourth Quarter of 2008 8FDA Accepts Investigational New Drug (IND) Application for Tigris Pharmaceutical's GGTI-2418 2Savara Expands Board of Directors, Appoints Three New Members 2Savara Expands Board of Directors, Appoints Three New Members 3
(Date:9/18/2014)... several disciplines will be celebrated tonight at the third ... improving the health of premature infants and in paving ... researchers, whose work was supported by the National Science ... Atomic Energy Commission, will be honored at a ceremony ... bipartisan group of Members of Congress will be on ...
(Date:9/18/2014)... cycles of carbon and nitrogen comprise all spheres ... environmental systems have caused imbalances and perturbations that ... (GHGs). Increased GHGs result in climate changes which ... oceans and the atmosphere. Understanding these feedback mechanisms ... of environmental science during the past three decades. ...
(Date:9/18/2014)... are too stressed they are often grouchy, grumpy, nasty, ... (BMI) at EPFL have just highlighted a fundamental synaptic ... the loss of social skills and cognitive impairment. When ... molecule in the brain. This was revealed by a ... Carmen Sandi,s team went to look for answers in ...
Breaking Biology News(10 mins):3rd annual Golden Goose award ceremony honors 8 researchers; Unusual work had big results 2Greenhouse gas research enters a new era 2How stress tears us apart 2
... looking good for him. Up until now he has been in ... he finishes first is often decided by just a few seconds. ... on the cross-country ski run, the condition of the athlete on ... Olympic skiing stars who are wooed by sponsors, up until now ...
... that celiac disease is increasing in prevalence because farmers are ... conclusion of an article in the ACS, Journal of ... evidence that the incidence of celiac disease increased during the ... the disease is 4 times more common today. Also known ...
... Michael Pogue, a Research Entomologist in the ARS ... , Washington, DC, was sent a series of moth ... under consideration as a possible biocontrol agent for the ... species was initially identified as a common species, but ...
Cached Biology News:Optimized custom-made ski sledges 2Optimized custom-made ski sledges 3Biocontrol research on Brazilian peppertree in Florida discovers new cryptic species 2